Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

JNJ 101.46 -0.91 (-0.89%)
price chart
'Frozen,' 'Star Wars' fuel Band-Aid comeback for Johnson & Johnson
When Greg Marcotte's daughters scrape a knee, they paste on a Band-Aid that's more than just a way to cover a wound. "I almost feel like they're a fashion accessory," Marcotte, a high school math teacher in Worcester, Mass.
Court revives Oregon suit over Johnson & Johnson's 'phantom recall' of Motrin
PORTLAND - A lawsuit over Johnson & Johnson's buyback of defective Motrin pills has been given new life by the Oregon Court of Appeals.
Oregon lawsuit over Motrin maker's 'phantom recall' revived on ...
How Johnson & Johnson Spent $71 Billion in 12 Months
Business is good at Johnson & Johnson (NYSE:JNJ). Over the last 12 months, it's earned $71 billion in revenue, ranking 40th among S&P 500 companies.
News Review: Huntsman Corporation (HUN), Silver Wheaton Corp USA (SLW ...  Investor Wired
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
16, Johnson & Johnson announced that the Food and Drug Administration had approved Darzalex (scientifically known as daratumumab) for the treatment of relapsed multiple myeloma in patients who have tried and progressed on at least three therapies.
Johnson & Johnson Multiple Myeloma Drug Wins Accelerated OK
A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple myeloma in patients who've failed prior therapies and have few options left.
Johnson & Johnson (JNJ) Rating Increased to Buy at Vetr Inc.
Johnson & Johnson logo Johnson & Johnson (NYSE:JNJ) was upgraded by Vetr from a “hold” rating to a “buy” rating in a report released on Monday, MarketBeat.
Why Johnson & Johnson Stock Is a Better Buy Than Pfizer
Johnson & Johnson is well-known for its consumer brands, while Pfizer is more often compared with purer-play drugmakers Merck & Co.
Do Hedge Funds Love Johnson & Johnson (JNJ)?
Johnson & Johnson investors should pay attention to a decrease in activity from the world's largest hedge funds of late.
5 Things Johnson & Johnson Wants You to Know
It's been a few weeks since healthcare conglomerate Johnson & Johnson (NYSE:JNJ) reported its third-quarter earnings results, handily surpassing Wall Street's profit estimates once again, and investors have now had a little time to digest what Johnson ...
Better Dividend Stock: Johnson & Johnson vs. Eli Lilly and Company
Two companies that currently offer their investors big dividend checks right now are pharma giants Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ). Both of these companies produce billions in revenue and have been putting cash in their investors' ...